PCSK9 and prostate carcinoma: In the main analysis of prostate cancer, fixed-effect IVW models were used for HMG-CoA reductase and NPC1L1 because of no heterogeneity, while random effect IVW model was also used for PCSK9 (Additional file 1: Table S2).